Towards graft-<i>versus</i>-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia
Hematopoietic stem cell transplantation is a well-established treatment option for acquired aplastic anemia. Historically, upfront hematopoietic stem cell transplantation (HCT) with HLA-matched sibling donors is used in young patients and immunosuppressive therapy (IST) is used for all others. Over...
Saved in:
| Main Authors: | Joseph H. Oved, Andrea Bacigalupo, Amy E. DeZern |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-05-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12079 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical case of acquired idiopatic aplastic anemia
by: A. V. Serezhkina, et al.
Published: (2023-07-01) -
REFRACTORINESS TO DONOR PLATELETS TRANSFUSION IN PATIENTS WITH APLASTIC ANEMIA AND HEMOBLASTOSIS
by: A. F. Rakhmani, et al.
Published: (2018-07-01) -
Mature megakaryocytes acquire immune characteristics in a mouse model of aplastic anemia
by: Ashvind Prabahran, et al.
Published: (2025-07-01) -
Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia
by: Vivian Fonseca Gonzaga, et al.
Published: (2017-01-01) -
Safety and efficacy of romiplostim in children with acquired aplastic anemia who are naïve to immunosuppressive therapy
by: Mohammadreza Bordbar, et al.
Published: (2025-07-01)